Related Experiment Videos
Sudden death in hypertrophic and dilated cardiomyopathy
1Third Department of Medicine, Kurume University School of Medicine, Japan.
Japanese Circulation Journal
|December 1, 1989
Summary
Sudden death risk in hypertrophic cardiomyopathy (HCM) is higher in young patients with poor heart function. Dilated cardiomyopathy (DCM) patients may benefit from improved ventricular function to prevent sudden death.
Area of Science:
- Cardiology
- Clinical Medicine
- Electrophysiology
Background:
- Hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) are significant causes of cardiac morbidity.
- Sudden death (SD) is a critical concern in patients with these cardiomyopathies.
- Identifying predictors of SD is crucial for risk stratification and management.
Purpose of the Study:
- To investigate clinical variables predicting sudden death (SD) in patients with hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM).
- To differentiate risk factors and mechanisms for SD based on age in HCM patients.
- To evaluate potential strategies for preventing SD in both HCM and DCM.
Main Methods:
- Long-term prognosis of 314 HCM patients and 82 DCM patients was analyzed.
- Clinical variables, including age, left ventricular function, and electrocardiographic findings, were assessed.
- Correlation between these variables and occurrence of sudden death was examined.
Main Results:
- In HCM, 68% of cardiac deaths were sudden. Young age (<30 years), reduced fractional shortening (<35%), and elevated left ventricular end-diastolic pressure (≥20 mmHg) predicted SD.
- In HCM patients <30 years, exercise-induced ischemia was a likely mechanism for SD. In those 30-50 years, ventricular tachycardia was more prevalent.
- In DCM, 24% of cardiac deaths were sudden; no reliable predictors were identified, but improved ventricular function may be key.
Conclusions:
- Young HCM patients with impaired systolic and diastolic function face a high risk of SD, necessitating exercise restriction.
- For HCM patients aged 30-50, controlling ventricular tachycardia with antiarrhythmic agents is advised.
- For DCM, improving ventricular function appears to be the primary strategy to prevent SD, as antiarrhythmic agents may cause hemodynamic compromise.